Publisher
Springer Science and Business Media LLC
Reference68 articles.
1. Gamboa, A. C., Gronchi, A. & Cardona, K. Soft‐tissue sarcoma in adults: An update on the current state of histiotype‐specific management in an era of personalized medicine. CA: Cancer J. Clin. 70, 200–229 (2020).
2. Gronchi, A. et al. Histotype-tailored neoadjuvant chemotherapy versus standard chemotherapy in patients with high-risk soft-tissue sarcomas (ISG-STS 1001): an international, open-label, randomised, controlled, phase 3, multicentre trial. Lancet Oncol. 18, 812–822 (2017).
3. Weitz, J. R., Antonescu, C. R. & Brennan, M. F. Localized extremity soft tissue sarcoma: improved knowledge with unchanged survival over time. J. Clin. Oncol. 21, 2719–2725 (2003).
4. Schneider, P. & Ghert, M. Surveillance AFter Extremity Tumor surgerY (SAFETY): A Protocol for an International Randomized Controlled Trial. (2018).
5. Wilson, D. A. et al. Designing a rational follow-up schedule for patients with extremity soft tissue sarcoma. Ann. Surg. Oncol. 27, 2033–2041 (2020).